Ching Jaw is SVP Finance & CFO of CYTOKINETICS INC. Currently has a direct ownership of 57,346 shares of CYTK, which is worth approximately $3.18 Million. The most recent transaction as insider was on Mar 06, 2023, when has been sold 2,403 shares (Common Stock) at a price of $39.13 per share, resulting in proceeds of $94,029. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 57.3K
0% 3M change
0% 12M change
Total Value Held $3.18 Million

Ching Jaw Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 06 2023
SELL
Payment of exercise price or tax liability
$94,029 $39.13 p/Share
2,403 Reduced 4.02%
57,346 Common Stock
Mar 06 2023
BUY
Grant, award, or other acquisition
-
30,000 Added 25.57%
87,346 Common Stock
Mar 02 2023
SELL
Payment of exercise price or tax liability
$246,510 $39.6 p/Share
6,225 Reduced 9.44%
59,749 Common Stock
Feb 16 2023
SELL
Payment of exercise price or tax liability
$53,397 $44.13 p/Share
1,210 Reduced 1.8%
65,974 Common Stock
Feb 03 2023
SELL
Open market or private sale
$675,000 $45.0 p/Share
15,000 Reduced 18.25%
67,184 Common Stock
Feb 03 2023
BUY
Exercise of conversion of derivative security
$181,500 $12.1 p/Share
15,000 Added 15.43%
82,184 Common Stock
Apr 05 2022
SELL
Open market or private sale
$420,000 $42.0 p/Share
10,000 Reduced 12.97%
67,109 Common Stock
Apr 05 2022
BUY
Exercise of conversion of derivative security
$121,000 $12.1 p/Share
10,000 Added 11.48%
77,109 Common Stock
Apr 04 2022
SELL
Open market or private sale
$600,000 $40.0 p/Share
15,000 Reduced 18.27%
67,109 Common Stock
Apr 04 2022
BUY
Exercise of conversion of derivative security
$181,500 $12.1 p/Share
15,000 Added 15.45%
82,109 Common Stock
Mar 09 2022
SELL
Open market or private sale
$570,000 $38.0 p/Share
15,000 Reduced 18.27%
67,109 Common Stock
Mar 09 2022
BUY
Exercise of conversion of derivative security
$181,500 $12.1 p/Share
15,000 Added 15.45%
82,109 Common Stock
Mar 07 2022
SELL
Payment of exercise price or tax liability
$202,933 $36.83 p/Share
5,510 Reduced 7.59%
67,109 Common Stock
Mar 02 2022
SELL
Payment of exercise price or tax liability
$130,125 $37.63 p/Share
3,458 Reduced 6.17%
52,619 Common Stock
Mar 02 2022
BUY
Grant, award, or other acquisition
-
20,000 Added 21.59%
72,619 Common Stock
Feb 28 2022
SELL
Payment of exercise price or tax liability
$73,254 $35.32 p/Share
2,074 Reduced 3.57%
56,077 Common Stock
Feb 16 2022
BUY
Grant, award, or other acquisition
-
5,022 Added 7.95%
58,151 Common Stock
Oct 19 2021
SELL
Open market or private sale
$1,275,096 $35.73 p/Share
35,687 Reduced 40.21%
53,064 Common Stock
Mar 08 2021
SELL
Payment of exercise price or tax liability
$79,639 $19.19 p/Share
4,150 Reduced 4.48%
88,492 Common Stock
Mar 02 2021
BUY
Grant, award, or other acquisition
-
25,000 Added 21.25%
92,642 Common Stock
Mar 01 2021
SELL
Payment of exercise price or tax liability
$27,209 $19.66 p/Share
1,384 Reduced 2.01%
67,642 Common Stock
Feb 26 2021
SELL
Payment of exercise price or tax liability
$81,532 $18.73 p/Share
4,353 Reduced 5.93%
69,026 Common Stock
Oct 05 2020
SELL
Open market or private sale
$825,000 $30.0 p/Share
27,500 Reduced 27.28%
73,300 Common Stock
Oct 05 2020
BUY
Exercise of conversion of derivative security
$247,775 $9.01 p/Share
27,500 Added 23.75%
88,300 Common Stock
CJ

Ching Jaw

SVP Finance & CFO
South San Francisco, CA

Track Institutional and Insider Activities on CYTK

Follow CYTOKINETICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTK shares.

Notify only if

Insider Trading

Get notified when an Cytokinetics Inc insider buys or sells CYTK shares.

Notify only if

News

Receive news related to CYTOKINETICS INC

Track Activities on CYTK